Search alternatives:
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1601
-
1602
-
1603
-
1604
RFR magnitude as a function of time after stimulus level changes (“transient”) and steady state response magnitude to the same stimulus level.
Published 2018“…The left column–records after level changes from 40-dB (A) to 10-dB (D) increase; the right panel–records from 40-dB (E) to 10-dB (H) decrease. The legends show the levels before and during the recording window, e.g., “100–140”–level change from 100 (before the recording window) to 140 dB (during the recording window) re 1 μPa, “140–140”–steady-state level of 140 dB re 1 μPa. …”
-
1605
-
1606
-
1607
Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo.
Published 2013“…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”
-
1608
-
1609
-
1610
-
1611
Characteristics of the participants with normal or mildly decreased eGFR levels.
Published 2014“…The referent category for <i>P</i> value comparisons is eGFR higher than 90 mL/min/1.73 m<sup>2</sup>.</p><p>Characteristics of the participants with normal or mildly decreased eGFR levels.…”
-
1612
-
1613
-
1614
-
1615
-
1616
-
1617
-
1618
-
1619
-
1620